ObsEva is a clinical stage biopharmaceutical company focusing on the development of a novel generation of drugs addressing serious conditions compromising pregnancy from conception to birth.
- Year invested 2015
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Website obseva.com/
- Company Status IPO/Public (NASDAQ: OBSV)